The interdisciplinary approach to investigate bona fide agent(s) in flavonoids or alkaloids in treating HCC
Currently, the treatment of hepatocellular carcinoma (HCC) is yet to be determined, alternatively, flavonoids or alkaloids from nature have been considered as significant mediators against HCC. In the scenario, we pioneered the most significant agent(s) in either flavonoid(s) or alkaloid(s) against...
Saved in:
| Main Authors: | Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Goo-Hyun Kwon, Dong Joon Kim, Ki-Tae Suk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Artificial Cells, Nanomedicine, and Biotechnology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2024.2413536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01) -
Physicochemical and bioactive traits of black chickpea (Cicer arietinum) as affected by germination-induced modifications
by: Noor Shahid, et al.
Published: (2024-12-01) -
Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review
by: Fangying Su, et al.
Published: (2024-12-01) -
Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
by: Renlei Feng, et al.
Published: (2025-01-01) -
KLAUZULA EX BONA FIDE W FORMUŁCE KOMODATU
by: Jan Zabłocki
Published: (2017-05-01)